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Abstract Nanotechnology is a fast-growing area, involv-
ing the fabrication and use of nano-sized materials and
devices. Various nanocomposite materials play a number of
importantrolesinmodernscienceandtechnology.Magnetic
and ﬂuorescent inorganic nanoparticles are of particular
importanceduetotheirbroadrangeofpotentialapplications.
It is expected that the combination of magnetic and ﬂuo-
rescent properties in one nanocomposite would enable the
engineering of unique multifunctional nanoscale devices,
which could be manipulated using external magnetic ﬁelds.
The aim of this review is to present an overview of bimodal
‘‘two-in-one’’ magnetic-ﬂuorescent nanocomposite materi-
als which combine both magnetic and ﬂuorescent properties
inoneentity,inparticularthosewithpotentialapplicationsin
biotechnology and nanomedicine. There is a great necessity
for the development of these multifunctional nanocompos-
ites, but there are some difﬁculties and challenges to
overcome in their fabrication such as quenching of the
ﬂuorescent entity by the magnetic core. Fluorescent-
magnetic nanocomposites include a variety of materials
including silica-based, dye-functionalised magnetic nano-
particles and quantum dots-magnetic nanoparticle
composites.Theclassiﬁcationandmainsynthesisstrategies,
along with approaches for the fabrication of ﬂuorescent-
magnetic nanocomposites, are considered. The current and
potentialbiomedicaluses,includingbiologicalimaging,cell
tracking, magnetic bioseparation, nanomedicine and bio-
and chemo-sensoring, of magnetic-ﬂuorescent nanocom-
posites are also discussed.
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Introduction
The term ‘‘nanotechnology’’ is traditionally used to
describe materials with a size \100 nm and is an ever-
growing and interesting research ﬁeld to be a part of.
Although the ‘‘nano’’ preﬁx has been used to provide a new
host of buzzwords, chemists have been dealing in the
nanoscale since the ﬁrst chemical synthesis. In practise,
nanotechnology combines chemistry, materials science,
engineering and physics to provide new materials which
have potential applications in biology, medicine, informa-
tion technology and environmental science. Recent
advances in nanoscience have allowed researchers to apply
revolutionary new approaches in their research at molec-
ular and biological cellular levels, thereby advancing the
understanding of processes in a host of areas which
up to now had not been possible to study, in particular
nano-bio-technology [1, 2].
Because their properties differ from those of their bulk
counterparts, nanoparticles offer a range of potential
applications based on their unique characteristics. In
particular, magnetic nanomaterials represent one of the
most exciting prospects in current nanotechnology.
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have been injected into the body to a site of interest,
thereby acting as site-speciﬁc drug delivery vehicles.
Magnetic nanoparticles may be used as contrast agents in
magnetic resonance imaging (MRI). Magnetic nanoparti-
cles can also heat up once subjected to an external
magnetic AC ﬁeld, which opens up possibilities in hyper-
thermic cancer treatment. The area of magnetic
nanoparticles is therefore not only enticing in terms of
applications, but it also represents an exciting and fast
growing ﬁeld.
Magnetic iron oxide-based nanoparticles, such as mag-
netite (Fe3O4), maghemite (c-Fe2O3) and cobalt ferrite
(CoFe2O4), are the members of the ferrite family. Ferri-
magnetic oxides exist as ionic compounds, consisting of
arrays of positively charged iron ions and negatively
charged oxide ions. Ferrites adopt a spinel structure based
on a cubic close packed array of oxide ions. If magnetic
particles are of very small sizes (of the order of 10 nm)
they can demonstrate superparamagnetic behaviour [3].
Superparamagnetic particles consist of a single magnetic
domain where the particle is in a state of uniform mag-
netisation at any ﬁeld. Superparamagnetism arises as a
result of magnetic anisotropy, i.e. the spins are aligned
along a preferred crystallographic direction. If the sample
is made up of smaller particles, the total magnetisation
decreases with decreasing particle size [3]. It is clear that
the nanoparticle size plays an important role in determining
the magnetic response of the material and hence heavily
inﬂuences its biomedical activity. There has been much
recent work on the fabrication of monodisperse nano-sized
magnetic materials (Fig. 1a, b) and this has been the focus
of several reviews [4–6].
One of the attractive possibilities of magnetic nanopar-
ticles is the fact that they can be relatively easily
functionalised with molecules which may bestow new
properties on the particles. These include drug molecules,
ﬂuorescent compounds and various hydrophobic and
hydrophilic coatings. The focus of this review is the
association of magnetic and ﬂuorescent entities. Fluores-
cent dye molecules are most commonly used for biological
staining and labelling. There are many examples of organic
dyes used in biology in the literature, for example, DAPI,
Mitotracker and Hoescht dyes are used to label cellular
features. Another family of nanomaterials receiving con-
siderable attention over the last number of years is the
quantum dots (QDs) (Fig. 1c).
These ﬂuorescent semiconductor (e.g. II–VI) nanocrys-
tals have a strong characteristic spectral emission, which is
tuneable to a desired energy by selecting variable particle
size, size distribution and composition of the nanocrystals.
QDs have attracted enormous interest due to their unique
photophysical properties and range of potential applica-
tions in photonics and biochemistry [9, 10].
With advances in current organic and bioorganic
synthetic chemistry, capping group formation and biocon-
jugation strategies, QDs are becoming more widely used as
biological imaging agents [9, 11–13]. QDs can be treated
with drug moieties, for example, non-steroidal anti-
inﬂammatory drugs, in order to speciﬁcally target certain
organs or cell organelles [14]. One of the attractive prop-
erties of QDs is the fact that their emission spectra may be
tuned by varying the primary particle size or composition.
QDs which emit at several different wavelengths can be
excited with a single wavelength and are suitable for the
multiplex detection of a number of different targets in a
single experiment [15]. QDs also have advantages over
commercially available dyes in that they are less likely to
be bleached due to their high photochemical stability [9].
As we can see, both magnetic and ﬂuorescent inorganic
nanoparticles have been shown to play a signiﬁcant role in
nanotechnology. Just looking at the wealth of possible
applications open to magnetic and ﬂuorescent materials, it
is not hard to see why the combination of these two entities
opens up the opportunity to provide new nanocomposites
which could act as multi-targeting, multi-functional and
multi-treating tools. It is expected that the combination of
magnetic and ﬂuorescent properties in one nanocomposite
would open up great prospects both in nano- and bio-
technology, enabling the engineering of unique targeted,
nanoscale photonic devices which could be manipulated
using an external magnetic ﬁeld. Here, we hope to dem-
onstrate the importance of these new bimodal ‘‘two-in-
one’’ magnetic-ﬂuorescent nanocomposite materials and
explore their preparation and potential applications as
biomedical agents.
Fig. 1 (a, b) TEM images of
monodisperse magnetite
nanoparticles (from [7]); (c) Ten
distinguishable emission colours
of ZnS-capped CdSe QDs
excited with a near-UV lamp
(from [8])
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123Motivation and Main Challenges for the Development
of Magnetic-ﬂuorescent Nanocomposites
As discussed above, both magnetic and ﬂuorescent nano-
particles are of great scientiﬁc and technological
importance. The combination of a magnetic and a ﬂuo-
rescent entity may provide a new two-in-one multi-
functional nanomaterials with a broad range of potential
applications. First of all, multi-modal magnetic-ﬂuorescent
assays would be very beneﬁcial for in vitro- and in vivo-
bioimaging applications such as MRI and ﬂuorescence
microscopy. Second of all, these nanocomposites can be
utilised as agents in nanomedicine. For example, one of
their most promising applications is a bimodal anticancer
therapy, encompassing photodynamic and hyperthermic
capabilities. Fluorescent-magnetic nanocomposites can
also serve as an all-in-one diagnostic and therapeutic
tool, which could be used, for example, to visualise and
simultaneously treat various diseases. Another exciting
application of magnetic-ﬂuorescent nanocomposites is in
cell tracking, cytometry and magnetic separation, which
could be easily controlled and monitored using ﬂuorescent
microscopy. Finally, these nanocomposites can be used as
nano-blocks to build various nanoelectronic and photonic
devices by applying an external magnetic ﬁeld to manip-
ulate or arrange the magnetic nanoparticles and using
ﬂuorescence confocal microscopy to visualise and control
their positioning. Thus magnetic-ﬂuorescent nanocompos-
ites are very promising materials, but there are some
challenges to overcome in their fabrication. One of the
main obvious problems is the complexity in the prepara-
tion of these nanocomposites, which frequently involves
a multi-step synthesis and many puriﬁcation stages.
Therefore, the production of magnetic-ﬂuorescent nano-
composites is quite technically and time demanding. A
speciﬁc difﬁculty in the preparation of two-in-one mag-
netic ﬂuorescent nanocomposites is the risk of quenching
of the ﬂuorophore on the surface of the particle by the
magnetic core. In addition, if there are a number of ﬂuo-
rescent molecules attached to the surface of the particle,
they may act to quench each other. For example,
quenching due to the interaction of the ﬂuorescent dye
Cy5.5 and the iron oxide nanoparticle to which is was
attached as been reported [16]. Inter-molecule quenching
has also been explored, with a lower number of Cy5.5
molecules per particle showing higher ﬂuorescence inten-
sity than particles prepared with a higher loading. In this
work, the authors have noted the efﬁcient quenching
ability of colloidal materials; in particular, colloidal gold
has been shown to quench ﬂuorophores ranging from
ﬂuorescein to Cy5.5. Non-radiative transfer has been
blamed for the quenching of ﬂuorescent molecules when
attached to both magnetic and gold nanoparticles [17]. The
ﬂuorescence intensity of magnetic-ﬂuorescent nanocom-
posites using ﬂuorescein and rhodamine has found to be
3.5 and 2 times lower than the dyes alone, respectively
[18]. This quenching process is believed to occur because
of ﬂuorophore contact with the metal oxide particle sur-
face, resulting in an energy transfer process. Similar
behaviour has been reported by Mandal et al [19] who
carried out the emulsiﬁcation in water of an oil-containing
oleic acid stabilised iron oxide particles and tri-n-octyl-
phosphine stabilised QDs. A decrease in the ﬂuorescence
intensity of the synthesised droplets was noted. Variation
of the iron oxide content from 0 to 51% (Cmax) caused a
decrease in the ﬂuorescence intensity by a factor of 100. At
higher iron oxide concentrations, the authors attribute the
quenching of the QDs to static and dynamic ﬂuorescence
quenching of the dots and to the strong absorption of the
transmitted light by the iron oxide particles. The problem
of quenching can be partially resolved by providing the
magnetic nanoparticle with a stable shell prior to the
introduction of the ﬂuorescent molecule, or by ﬁrst treating
the ﬂuorophore with an appropriate spacer. We will discuss
in detail the synthesis approaches which may be used to
provide magnetic-ﬂuorescent nanocomposites and the
routes taken to ensure quenching events are minimised.
Finally there are typical problems related to instability
and aggregation of the nanocomposites in solutions. The
aggregation can be caused by magnetic, electrostatic or
chemicalinteractionsbetweenparticles.Therefore,acareful
design and an extremely accurate synthesis methodology
are required for the development of the ﬂuorescent-
magnetic nanocomposites to avoid their aggregation and
precipitation.
Types of Magnetic-ﬂuorescent Nanocomposites
and Synthetic Approaches to their Preparation
The area of ﬂuorescent-magnetic nanocomposites is still
very much in its developing stage, making the classiﬁcation
of these materials difﬁcult and quite arbitrary. Most of
these nanocomposites are core-shell nanostructures. In
general, we can identify eight main types of ﬂuorescent-
magnetic nanocomposites (Fig. 2): (i) a magnetic core
coated with a silica shell containing ﬂuorescent compo-
nents; (ii) polymer-coated magnetic nanoparticles
functionalised with a ﬂuorescent moiety; (iii) ionic aggre-
gates consisting of a magnetic core and ﬂuorescent ionic
compounds; (iv) ﬂuorescently labelled bilipid-coated
magnetic nanoparticles; (v) a magnetic core covalently
bound to a ﬂuorescent entity via a spacer; (vi) a magnetic
core directly coated with a semiconducting shell; (vii)
magnetically doped QDs and (viii) nanocomposites, which
consist from magnetic nanoparticles and QDs encapsulated
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mainly based on the structure and synthesis strategies for
these materials.
Fluorophore Encapsulated Silica-coated Magnetic
Nanoparticles
There are several reasons for choosing silica as a coating
for magnetic particles in the fabrication of ﬂuorescent-
magnetic nanocomposites. First of all, the silica coating
provides an effective barrier to quenching of any ﬂuoro-
phores by the magnetic cores. In fact quenching can be
controlled by the thickness of the silica shell. Second of
all, the silica shell is relatively inert and optically trans-
parent allowing incorporation of ﬂuorescent dyes or QDs
directly into the shell. Thirdly, the silica surface can be
easily functionalised, enabling chemical bonding of vari-
ous ﬂuorescent and biological species to the surface.
Another important aspect is that the silica coating may
reduce any potential toxic effects of the bare nanoparti-
cles. It also helps to prevent particle aggregation and
increase their stability in solution. Because the isoelectric
point of magnetite is at pH 7, it is necessary to further
coat the particles in order to make them stable in the pH
region 6–10. Application of a thin layer of silica lowers
this isoelectric point to approximately pH 3, which
increases the stability near neutral pH [20]. Finally silica
coating has a signiﬁcant advantage over traditional sur-
factant coating such as lauric acid and oleic acid because
there is no risk of desorbtion of the strongly covalently
bound silica shells. There are a number of reports on the
preparation of ﬂuorescent-magnetic nanocomposites using
a silica-coating approach. A general description is given
in Fig. 3.
Lu et al. [21] have prepared a silica encapsulated com-
mercial ferroﬂuid (EMG 304, Ferroﬂuids) and have
controlled the thickness of the silica shell between 2 and
100 nm by changing the concentration of the TEOS pre-
cursor. The authors have found that the particle
monodispersitycanbeinﬂuencedbyincreasingthethickness
of the silica coating. The number of magnetic nanoparticles
per shell can also be controlled, with an increase in
monomers noted with decreasing iron oxide concentration.
By incorporating dyes such as 7-(dimethylamino)-4-meth-
ylcoumarin-3-isothiocyanate and tetramethylrhodamine-
5-isothiocyanate into the silica shell, magnetic-ﬂuorescent
Fig. 2 Main types of magnetic-
ﬂuorescent nanocomposites
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dyes are incorporated during the coating process—in effect,
the dye is trapped in the silica shell. The isothiocyanate
functionalitypresentonthedyemoietieshasbeencoupledto
3-aminopropyltriethoxysilane, which can be subsequently
co-hydrolysedinthepresenceofTEOSduringtheformation
of the silica shell coating the magnetic cores. Fluorescence
opticalmicroscopyconﬁrmstheﬂuorescentpropertiesofthe
dyes are not compromised. These composite materials can
then be aligned using an external magnetic ﬁeld. A similar
treatment has been employed with cobalt ferrite nanoparti-
cles. These particles were ﬁrst coated with a rhodamine B
iosothiocyanateincorporatedsilicashell,followedbyalayer
of biocompatible polyethylene glycol [22].
In order to produce a nanoclinic device capable of
speciﬁc recognition and cancer treatment, Levy et al. [23]
have used a sol–gel approach to coat maghemite nano-
particles with the silica shell, which also enables the
incorporation of a two-photon dye. The dye, (1-methyl-4-
(E)-2-(4-[methyl(2-sulfanylethyl)-amino]phenyl)-1-ethenyl)
pyridinium iodide or ASPI), was encapsulated in the silica
shell surrounding the magnetic core. Use of these com-
posites in cancer treatment is considered in Sect.
‘‘Biomedical Applications’’. A similar synthetic approach
has been used by Lin et al. [24] who have initially prepared
silica-coated magnetite nanoparticles, before adding
organic dyes, TEOS and a cetyltrimethylammonium bro-
mide (CTAB) stabiliser to provide mesoporous silica
nanoparticles. Hyeon and co-workers [25] have prepared
monodisperse oleic acid stabilised magnetite nanoparticles
and CdSe/ZnS QDs which were then simultaneously
embedded in mesoporous silica spheres. The 12-nm
magnetite nanoparticles have been transferred into water
by subsequent treatment with the above-mentioned
CTAB stabiliser, which also enabled the formation of the
silica spheres. The average size of these silica spheres
was 150 nm. Magnetisation measurements revealed that
the superparamagnetic behaviour of the particles was
maintained by embedding in the silica spheres. The
embedded QDs exhibited a slight red shift in their emission
spectra.
The surface of silica-coated magnetite nanoparticles has
also been coated with CdTe QDs by using a metal ion-
driven deposition technique [26]. Here, Cd
2+ ions, in the
form of CdCl2, are added to a stirred suspension of silica-
coated magnetite nanoparticles and TGA-stabilised CdTe
QDs. This results in the deposition of Cd
2+ ions on the
surface of the magnetite, which promotes the coaggrega-
tion of CdTe QDs. The Cd
2+ may act in two ways to attach
the QDs: (1) the ions may couple to surface Te atoms with
dangling bonds and complex with any residue-free TGA to
form thicker ligand shells; (2) the COO
- ions of the TGA
Magnetic
core
Si
OEt
OEt
OEt
EtO
Sodium silicate
Si
OEt
OEt
OEt H2N
Me4N+ OH-
Magnetic
core
Silica layer
NEt3
Magnetic
core
Further silica coating
Fluorophore
COOH
EDCI, 0 oC
C
O
H
N Si
OEt
OEt
OEt
NEt3
Magnetic
core
Fluorescent
coating
(i) (ii)
(iii)
(iv)
Fig. 3 Preparation of
ﬂuorescently labelled silica-
coated magnetic
nanocomposites. (i) Initial
optional coating with sodium
silicate; (ii) base catalysed
condensation of TEOS on
nanoparticle surface; (iii)
covalent attachement of
carboxyl ﬂuorophore to
3-aminopropyltriethoxysilane
via EDC coupling step; (iv)
condensation of silane-modiﬁed
ﬂuorophore onto silica-coated
magnetic particle
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2+
ions.
Interesting luminescent and paramagnetic hybrid silica
nanoparticles with a magnetic layer have been reported by
Rieter et al. [27]. In this case, a ruthenium complex is
incorporated within a silica nanoparticle that acts as the
luminescent core, while the paramagnetic component is
provided by a monolayer coating of different silylated Gd
complexes. These particles were prepared by a water-in-oil
reverse microemulsion procedure from [Ru(bpy)3]Cl2 and
TEOS by adding ammonia. In order to enhance the Gd
3+
loading capacity, mono- and bis-silylated Gd complexes
were synthesised and loaded onto the Ru complex-silica
cores. The particle size increases from 37 to 40 nm on
going from the mono to bis moieties. This is due to the
ability of the bis-silylated Gd complex to form multilayers
on the silica nanoparticle surface.
Up-converting ﬂuorescent magnetic nanoparticles with
covalently bound streptavidin have been synthesised using
ytterbium and erbium co-doped sodium yttrium ﬂuoride
(NaYF4:Yb, Er), which was deposited on iron oxide
nanoparticles by the co-precipitation of the rare-earth metal
salts in the presence of a chelator, EDTA [28]. The mag-
netic-ﬂuorescent nanoparticles were coated with a layer of
silica, before being covalently coupled to streptavidin
(Fig. 4). These are core-shell nanoparticles with a silica
coating of 20–30 nm, containing up-converting phosphors,
which emit up-conversion ﬂuorescence at 539 and 658 nm
when excited with a 980-nm laser. The hybrid particles
were also found to stack in chain-like assemblies when
subjected to an external magnetic ﬁeld. Protein arrays were
used to conﬁrm the successful binding of streptavidin, and
demonstrate one of the possible applications of the multi-
functional nanoparticles at the same time.
Enhanced luminescent behaviour of Ln ions (Ln = Eu,
Tb) bound to silica-coated magnetic nanoparticles has been
reported by Hur and co-workers [29]. This increase is
attributed to an efﬁcient ligand-to-metal energy transfer.
The lanthanide ions have been bound to the silica-coated
particles by reaction with 2, 20-bipyridine-4, 40-dicarbox-
ylic acid, whose carboxylate groups can bind to the silica
and bi-pyridinyl groups can covalently bond to the Ln ions.
The authors speculate that the carboxylate groups most
likely coordinate to the silica surface in a bridged or
bi-dentate fashion, rather than a mono-dentate one.
Polymer-coated Magnetic Cores Treated
with Fluorescent Entities
Various self-assembly techniques utilising polymers or
polyelectrolytes (PE) have recently received considerable
interest. Particles can be either stabilised or caused to
ﬂuocculate as a result of both electrostatic and steric
effects originating from PE. The use of several charged
layers to provide a coating around the nanoparticle core
has been termed the layer-by-layer technique. The method
has several advantages including the possibility of tuning
the polymer-coating thickness and allowing deposition of
a monolayer of charged particles or molecules. By
employing this approach, Hong et al. [30] have exploited
the electrostatic interactions of PE with the negatively
charged surface of magnetic nanoparticles followed by the
addition of CdTe QDs to prepare the magnetic-ﬂuorescent
nanocomposites. The thickness of the polyelectrolyte
coating can be tuned by successive additions of oppositely
charged PE, e.g. poly(allylamine hydrochloride) and
poly(sodium 4-styrenesulfonate) (Fig. 5). The presence of
the polyelectrolyte was conﬁrmed by zeta potential
Fig. 4 Preparation of streptavidin-immobilised ﬂuorescent-magnetic
nanocomposites; ﬂuorescent microscopy images of nanocomposites
excited with a 980 nm laser; (a) image of chain-like structures formed
by nanocomposites in the presence of an external ﬂat magnetic ﬁeld;
(b) image of stack-like structures formed by the same nanoparticles in
an external needle-like magnetic ﬁeld. From [28]
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change upon treatment with an oppositely charged species.
Similarly, by alternate deposition and adsorption of
charged polyelectrolyte interlayers and QD/polyelectrolyte
multilayers, Fe3O4/PEn/CdTe and Fe3O4(PE3/CdTe)n core-
shell nanocomposites were prepared [31]. The ﬂuorescence
intensity of the composites was found to vary according to
the distance between the magnetic core and QD layer.
Kitagawa and co-workers [32] have prepared multi-func-
tional magnetic particle by using polyelectrolyte multi-
layers of cationic ﬂuorescent and anionic polymers as the
inner and outer layers, respectively, on the surface of the
magnetic nanoparticles. Poly(ethyleneimine) (a cationic
polyelectrolyte) was labelled with rhodamine B isothiocy-
anate and adsorbed onto carboxylate functionalised
magnetic particles. The negatively charged polyelectrolyte
DxS was then added to a suspension of the rhodamine-
treated particles, producing a polyelectrolyte coating of
several nanometres.
A rather different chemical approach via thiol coupling
hasbeenusedbyRosenzweigandco-workers[33]inorderto
covalently attach CdSe/ZnS QDs to commercially available
polymer-coated maghemite (c-Fe2O3) beads. The QDs were
capped with trioctylphosphineoxide (TOPO) and were sol-
uble in chloroform. This presented a challenge, as the aim
was to couple these QDs to water-soluble magnetic beads
whichhadbeentreatedwithDMSA,providingfreethioland
carboxyl residues for covalent attachment. In order to
overcomethis,theauthorscarriedoutthereactionina10:5:1
mixture of chloroform/methanol/water. By using an excess
of QDs to magnetic beads (100:1), the reaction proceeded
andtheimmobilisationwasveriﬁedbyanobservedblueshift
in the luminescence spectra of the QDs. A lower quantum
yield of up to three times less than the original QDs in
chloroform was noted. This decrease was attributed to
quenching the interactions between the magnetic particles
and the QDs or between the closely packed QDs.
There have also been several reports of magnetic
nanoparticles and QDs encapsulated within a polymer or
silica matrix, allowing for the preparation of ﬂuorescent
entities which can be manipulated by an external magnetic
ﬁeld [34–36].
Ionic Assemblies of Magnetic Cores and Fluorescent
Entities
Electrostatic interactions have also been utilised in order to
provide new ﬂuorescent-magnetic nanocomposites. The
interactions among the core nanoparticle, the spacer group
and the ﬂuorophore have been employed to prepare new
ﬂuorescent magnetite-porphyrin nanocomposites (Fig. 6)
[37]. In this case, a polyhedral silsesquioxane was syn-
thesised, which could ionically interact with the negatively
charged magnetic nanoparticles. A carboxylic acid por-
phyrin derivative was chosen, which could electrostatically
interact with the positively charged amino spacer [38].
Porphyrins are biocompatible ﬂuorescent compounds
which have been used as efﬁcient photosensitisers for
photodynamic therapy (PDT), a technique whereby tumour
tissue is destroyed by the uptake of the dye and subsequent
irradiation with visible light [39, 40]. By bringing together
these entities, the resulting nanocomposites may ﬁnd
applications in hyperthermia and PDT, as well as providing
a synthesis route to new drug delivery systems.
M_ enager and co-workers [18] have used co-precipitated
maghemite nanoparticles in conjunction with two different
dyes—rhodamine B and a ﬂuorescein derivative—to pro-
vide a new composite which enter live cells and resides in
the cell endosomes. These authors present some interesting
results including the observation of chain like assemblies
of the endosomes due to the accumulation of the magnetic
nanocomposites. In order to prepare these composites, the
dye is ﬁrst EDC coupled to dimercaptosuccinic acid
(DMSA), which is itself positively charged and can interact
strongly with the negatively charged nanoparticle surface.
Hydrophilic, highly luminescent magnetic nanocom-
posites based on the connection of QDs and magnetic
nanoparticles through charge interactions have been pre-
pared by You et al. [41]. In this work, positively charged
magnetite nanoparticles and negatively charged TGA-cap-
ped QDs have been synthesised. In order to maintain these
charges and improve the attachment of the QDs to the
magnetic nanoparticles, the pH was adjusted to 3. This
lower pH caused the QDs to ﬂocculate and once the mag-
netic nanoparticles are added to a suspension of these QDs,
Fe3O4 Fe3O4 Fe3O4
1. PAH 2. PSSS
Fe3O4
Successive PE
layers
Fig. 5 Layer-by-layer treatment of magnetite nanoparticles with positively charged polyallylamine hydrochloride and negatively charged poly
sodium(styrene sulfonate) PE)
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previously [19], a decrease in luminescence intensity was
attributed to dynamic or static quenching of the QDs.
Fluorescently Labelled Lipid-coated Magnetic
Nanoparticles
Lipid layers are frequently used to improve the stability
and biocompatibility of nanoparticles. This technique is
based on the coating of the nanoparticle surface by
amphiphilic lipid molecules, which could then be linked to
various species. There are several reports on the utilisation
of this approach for the preparation of ﬂuorescent-magnetic
nanocomposites. In one of these works, magnetite nano-
particles coated with an oleate bilipid layer have been
conjugated to biotin in order to bind streptavidin-ﬂuores-
cein isothiocyanate [42]. This receptor recognition-based
synthesis allows for the preparation of magnetic-ﬂuores-
cent nanocomposites, which have been studied using ﬂow
cytometry and ﬂuorescence microscopy. A similar
approach has been used by Zhang and co-workers [43] who
have prepared a sandwich-type immunoassay by func-
tionalising dextran-coated magnetic nanoparticles with a
primary antibody via a Schiff base reaction and reacting
them with CdTe QD-secondary antibody conjugates.
A dual modality contrast agent, based on gadolinium-
rhodamine nanoparticles, has been prepared by Vuu et al.
[44]. The 85-nm nanoparticles were prepared by mixing the
gadolinium and rhodamine lipid monomers together with 1,
2-dioleoyl-3-trimethylammonium propane and 1-palmi-
toyl-2, 10, 12-tricosadiynoyl-sn-glycero-3-phosphocholine
in darkness, followed by ultrasonic and UV treatment
(Fig. 7).
Two types of lipid-based magnetic contrast agents, one
based on gadolinium and ﬂuorescent entities combined in a
bilipid layer and the second on a hydrophobic iron oxide
nanoparticleinaﬂuorescentlipid-containingmicellularshell,
have been prepared by van Tilborg et al. [45]. Amphiphiles
with functional headgroups were chosen in order to allow the
covalent coupling of annexin A5 proteins for targeting.
In other works, these authors have further developed new
liposomal Gd chelate-based ﬂuorescent-magnetic nanocom-
posites [46, 47]. These nano-sized lyposomes consist of a
commercially available Gd–DTPA complex attached to two
stearyl chains, a ﬂuorescent lipid, 1,2-distearoyl-sn-glycero-
3-phosphocholine (DSPC), cholesterol and a 1,2-distearoyl-
sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene
glycol)-2000 (PEG–DSPE) conjugate (Fig. 8). These
nanocomposites can also be easily coupled to antibodies
and other biomolecules enabling various biological
applications.
In another study, superparamagnetic iron oxide nano-
particleswereencapsulatedinaPEG-modiﬁedphospholipid
micelle structure and have been conjugated to the ﬂuores-
centTexasreddyeandtheTatpeptideusingN-succinimidyl
3-(2-pyridyldithio)propionate as a cross-linking reagent.
Thisapproachresultedinsmall,uniformlysizedﬂuorescent-
magnetic nanocomposites which are biocompatible, water
soluble and stable [48]. Taton and co-workers [49] have
prepared ‘‘magnetomicelles’’ by coating hydrophobic
magnetic nanoparticles with an amphiphilic polystyrene250-
block-poly(acrylic acid13) block copolymer. These com-
posites are water soluble due to the presence of the PAA
outer block and by ensuring only 50% of the surfactant is
cross-linked, further functionalisation is possible via
attachment to the remaining carboxylic acid groups present.
Bioconjugation was achieved by employing a technique
called immobilised metal afﬁnity chromatography. The
protein loading capacity was determined by analysing the
ﬂuorescence spectra of particles conjugated to His-6 tagged
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123enhanced green ﬂuorescent protein (EGFP). The ﬂuores-
cence intensity of the samples indicates that the EGFP
remains intact after conjugation to the magnetomicelle
surface.
Magnetic Core Directly Linked to Fluorescent Entity
via a Molecular Spacer
Direct linking of a ﬂuorescent moiety to a magnetic core
normally requires the use of a sufﬁciently long molecular
linker in order to bypass any possible quenching by the
paramagnetic core. The most common strategy is to use
magnetic nanoparticles capped by a stabilising agent,
which contains several functional groups available for
further functionalisation. For example, citric acid capped
magnetite nanoparticles have been covalently bound to
ﬂuorescent dyes, including Rhodamine 110, via carbodi-
imide coupling reaction. This process resulted in new
nanocomposites suitable for further biological studies [50].
In one study, Cheon and co-workers [51] prepared a
monodisperse organic-stable suspension of 9 nm Fe3O4
nanoparticles which was phase transferred into aqueous
solution via the addition of 2,3-DMSA. The DMSA acts
not only to make the particles water soluble but also
provides additional anchorage sites for the attachment of
a ﬂuorescent dye-labelled cancer-targeting antibody, in
this case Herceptin. Porphyrin-coated magnetic nickel
nanowires have been prepared by Tanase et al. [52]b y
using ultrasonic effects to produce a covalent bond
between the nickel oxide surface and the carboxylic acid
groups of a porphyrin molecule. The main aim of this
work was to assemble ordered arrays of nanowires with
enhanced anisotropy. Porphyrin derivatives have also
been employed by Gu et al. [53] who have reported the
preparation of porphyrin-functionalised magnetite nano-
particles using catechol chemistry to provide a covalent
link between the magnetic cores and the ﬂuorescent entity
(Fig. 9).
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123This involved the activation of a dopamine derivative
with N-hydroxysuccinimide, followed by a reaction with
diaminoporphyrin to form an ester bond. After a depro-
tection step to remove the benzyl groups of the dopamine, a
direct linkage to the magnetite nanoparticle surface was
achieved.
Magnetic Core Directly Coated by Fluorescent
Semiconducting (II–VI) Shell
There are several reports on nanocomposites where the
magnetic core has been directly coated by II–VI semi-
conducting layers. In one, a CdS shell was deposited on the
surface of FePt nanoparticles to form a ﬂuorescent-mag-
netic core-shell nanostructure (Fig. 10)[ 54]. This was
achieved by a relatively simple one pot synthesis, which
involved the following steps: (1) the thermolysis of
Fe(CO)5 and the reduction of Pt(acac)2 by hexadecane-1,2
diol, resulting in FePt magnetic nanoparticles in dioctyl
ether; (2) the deposition of a sulphur layer on the particles
by the addition of elemental sulphur to the dioctyl ether
solution at 100 C; (3) the addition of TOPO, hexadecane-
1,2-diol and Cd(acac)2 at 100 C yielding a metastable
core-shell FePt@CdS structure and ﬁnally (4) the trans-
formation of the CdS layer from amorphous to crystalline
by heating to 280 C . The mismatch of the lattices of FePt
and CdS and the surface tension force these core-shell
nanoparticles to evolve into ﬂuorescent superparamagnetic
heterodimers consisting of CdS and FePt nanocrystals of
\10 nm in size.
Klimov and co-workers [55] reported the synthesis of
Co/CdSe core-shell nanocomposites by controlled deposi-
tion of CdSe onto preformed Co nanocrystals. In this paper,
Co nanoparticles were prepared by high-temperature
decomposition of Co2(CO)8 in the presence of organic
surfactant molecules. The CdSe precursors (CdMe2 and Se)
in trioctylphosphine were then added to the Co nanoparti-
cles at 140 C and the mixture was kept at this temperature
overnight. Subsequent heating up to 200 C resulted in
Co/CdSe core shell nanocomposites with an average
diameter of 11 nm. This combination of magnetic nano-
particle and semiconducting QD demonstrated interesting
magnetic and ﬂuorescent behaviour.
A similar approach was used by Shim and co-workers
[56] to prepare a series of maghemite—metal sulphide
(ZnS, CdS and HgS) hetero-nanostructures. These nano-
composites have been prepared by direct addition of
sulphur and the appropriate metallorganic precursors to
preformed c-Fe2O3 nanoparticles, followed by high-tem-
perature treatment. Similar to the above heterodimers, the
large lattice mismatch between c-Fe2O3 and metal sulphide
nanocrystals resulted in the formation of non-centrosym-
metric nanostructures. Preferential formation of trimers and
higher oligomers was observed for ZnS and dimers or
isolated particles for CdS and HgS nanocomposites.
However, the ﬂuorescent and magnetic properties of these
nanocomposites have not yet been investigated.
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123In another report, magnetite nanoparticles prepared via a
high-temperature decomposition method have been coated
with CdSe followed by deposition of a layer of ZnS by Du
et al. [57]. The quantum yield was measured against a
rhodamine B standard and was found to increase from 2–3
to 10–15% upon addition of the ZnS shell. This increase is
owing to the decrease in the number of defects in the
Fe3O4/CdSe shell. Magnetisation measurements showed no
coercivity or remanence at 2 K, indicating the presence of
paramagnetic material.
Magnetically Doped QDs
Water dispersible, multi-functional CdS:Mn/ZnS magneti-
cally doped QDs have been prepared using a water-in-oil
microemulsion method [58]. Using this approach, manga-
nese doped QDs have been fabricated by mixing sodium
sulphide with cadmium and manganese(II) acetates in
dioctyl sulfosuccinate, heptane and water in the appropriate
ratio. A zinc salt was then added to grow a uniform ZnS
shell. A bright yellow emission is observed due to surface
passivation by the epitaxially matched ZnS crystalline
layer around the CdS:Mn crystalline core. These materials
have demonstrated ﬂuorescent, radio-opaque and para-
magnetic properties and can be further functionalised with
biomolecules such as DNA, proteins, peptides or antibod-
ies. More recently, these authors have reported the
functionalisation of these magnetically doped QDs with
Gd(III) ions for applications in MR contrast imaging [59].
The silica-coated CdS:Mn/ZnS QDs were treated with the
chelating silane coupling agent triacetic acid trisodium salt,
allowing subsequent coordination of Gd(III) ions.
Biomedical Applications
Multi-functional nanomaterials possessing ﬂuorescent
and magnetic properties may be used in a number of
biomedical applications in nanobiotechnology, such as
bioimaging, bio- and chemo-sensing, cell tracking and
sorting, bioseparation, drug delivery and therapy systems in
nanomedicine.
Bioimaging Probes
Fluorescence microscopy and nuclear MRI are two main
imaging techniques which have had a tremendous impact
upon biomedical science in recent years. Unlike previous
approaches which may have required the processing of
ﬁxed tissue samples, these techniques allow for the imag-
ing of live and intact organisms both in vivo and in vitro,
resulting in a more realistic picture of the processes
occurring in live biological species. Frequently, these
imaging techniques are complimentary to each other and
could be used for parallel detection to have a clearer pic-
ture and provide a correct diagnosis. In this case,
ﬂuorescent-magnetic nanocomposites serve as new dual
function contrast agents, which can be used simultaneously
in confocal ﬂuorescent microscopy and in MRI. In addi-
tion, ﬂuorescent-magnetic nanocomposites allow us to
perform optical tracking of biological entities and pro-
cesses in combination with magnetophoretic manipulation.
There are several reports on the utilisation of multi-
functional ﬂuorescent-magnetic nanocomposites as con-
trast agents. These multi-functional materials are of
particular importance as probes and biological labels for
cellular imaging. Intracellular uptake and imaging using
magnetic ﬂuorescent nanoparticles prepared by M_ enager
and co-workers [18] have shown that, after cellular uptake,
these nanoparticles were conﬁned inside endosomes which
are submicrometric vesicles of the endocytotic pathway.
The authors have shown the possibility of magnetic
manipulation of these internalised nanocomposites, result-
ing in the formation of spectacular ﬂuorescent chains
aligned in the direction of the applied magnetic ﬁeld
(Fig. 11).
In another study, biocompatible PEG-modiﬁed, phos-
pholipid-coated iron oxide nanoparticles have been
conjugated to a ﬂuorescent dye and the Tat-peptide and
used for the imaging of primary human dermal ﬁbroblast
cells and Madin–Darby bovine kidney derived cells. These
micelle-coated iron oxide nanocomposites demonstrate
great potential for conjugation of a variety of moieties for
speciﬁc intracellular and tissue imaging [48]. The rhoda-
mine-labelled citric acid capped magnetite nanoparticles
have been used as ﬂuorescent biological markers. Confocal
ﬂuorescence microscopy demonstrated that these nano-
composites respond to an applied magnetic ﬁeld and are
Fig. 11 The overlay image of endosomes forming chains within the
cell cytoplasm in the direction of the applied magnetic ﬁeld (Bar
10 lm; magniﬁcation 1009). From [18]
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123taken up by KB cells in vitro. These materials can serve as
biocompatible ﬂuorescent ferroﬂuids, which enable optical
tracking of processes at the cellular level combined with
magnetophoretic manipulation [50].
Strong luminescence and high relaxivity at low ﬁeld
were demonstrated by a new type of ‘‘two-in-one’’ ﬂuo-
rescent-magnetic nanocomposites based on magnetite
nanoparticles, a polyhedral octaaminopropylsilsesquioxane
and a porphyrin derivative confocal imaging found that the
incubation of macrophage and bone osteoblast cells at the
presence of these nanocomposites resulted in their fast
intercellular localisation. The nanocomposites also exhib-
ited a distinctive subcellular distribution corresponding to
the location of the mitochondria, endoplasmic reticulum
and nuclei (Fig. 12). It was suggested that there is a dis-
sociation of the ionic components of the magnetic-
ﬂuorescent nanocomposites inside cells resulting in release
of porphyrin species, which can penetrate various intra-
cellular compartments. Such intracellular fragmentation of
the nanocomposites allows potential utilisation of these
new nanocomposites both as subcellular imaging contrast
agents and targeted drug delivery systems [37].
One of the important areas in which ﬂuorescent magnetic
nanoparticles have demonstrated great potential is in cancer
cell and tumour imaging. It has been shown recently that
human prostate, rodent prostate, human breast and mouse
mammary cancer cell lines can be readily labelled by
ﬂuorescent superparamagnetic particles composed of divi-
nyl benzene polymer containing magnetite nanoparticles
and a ﬂuorescein-5-isothiocyanate analogue within a
polymer matrix. Fluorescence stereomicroscopy and three-
dimensional MRI allowed in vivo imaging of intramuscular
or orthotopically implanted-labelled cancer cells. These
ﬂuorescent superparamagnetic particles were inert with
respect to cell proliferation and tumour formation and
served as both a negative contrast agent for in vivo MRI, as
well as a ﬂuorescent tumour marker for optical imaging
in vivo and in vitro [60].
Gd-based bimodal targeted liposomal contrast agents for
the detection of molecular markers, using both MRI and
ﬂuorescence microscopy, have been introduced by Mulder
and co-workers [45–47]. Conjugates of these contrast
agents with E-selectin-speciﬁc antibodies were tested on
human endothelial cells stimulated with tumour necrosis
factor. These conjugates have been shown to be excellent
contrast agents for both ﬂuorescence microscopy at the
subcellular level and for MRI on cell pellets. A series of
dual near-infrared ﬂuorescent-magnetic probes (CLIO-
Cy5.5) based on a superparamagnetic iron oxide core
coated with cross-linked dextran to which the ﬂuorochrome
Cy5.5 is covalently attached have been developed by
researchers in Harvard Medical School [16, 61]. These
nano-sized conjugates have been used for MRI and optical
imaging of various tumours in animal models. This
research has demonstrated that the utilisation of these dual
contrast agents and combination of two imaging techniques
(MRI and ﬂuorescent optical imaging) allowed for more
accurate localisation and delineation of tumour margins, an
important consideration for surgical resection of tumours
(Fig. 13)[ 61–64].
Fig. 12 Osteoblast cells uptake
of particles. Population imaging
(a) confocal image and (b)
overlay with phase contrast
(magniﬁcation 409, Scale
bar = 50 lm). Single cell
imaging. (c) confocal image and
(d) with combined phase
contrast (magniﬁcation 609,
Scale bar = 50 lm). From [37]
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labelled antibodies resulted in multi-functional magnetic
nanocomposites, which performed both in vitro and ex
vivo optical detection of cancer as well as in vivo MRI,
which are potentially applicable for an advanced multi-
modal detection system [51]. Recently, it was reported that
biotin-conjugated superparamagnetic Fe3O4 nanoparticles
have been functionalised by binding the ﬂuorescent tag
streptavidin-ﬂuorescein isothiocyanate (FITC) and, fol-
lowing uptake into HeLa cells, shown to confer magnetic
activity and ﬂuorescence labelling. It was found that these
nanocomposites were localised in the lysosomal compart-
ment of cells indicating a receptor-mediated uptake
mechanism [42]. It has also been reported that cobalt ferrite
nanoparticles coated with a silica shell containing organic
dye (FITC) and an antibody (Ab CD-10) can be speciﬁcally
taken up by leukaemia cells and A549 lung cancer cells.
This enabled selective ﬂuorescent labelling, imaging and
potentially sorting of the cells opening new prospects in
cancer diagnostics and therapy [65].
Ultimately ﬂuorescent magnetic nanoparticles show
great potential for imaging of brain-derived structures.
For example, ﬂuorescent superparamagnetic iron oxide
nanoparticles coated with functionalised polyvinyl alcohol
have been derivatised with a ﬂuorescent reporter molecule
and administered to a microglial cell culture, containing
immune cells of the nervous system. These nanocompos-
ites demonstrated good biocompatibility and strong
intracellular uptake. Hence, they have been envisaged as
potential vector systems for drug delivery to the brain,
which may be combined with MRI detection of active
lesions in neurodegenerative diseases [66]. In another
report, TAT (a cell penetrating peptide)-conjugated
CdS:Mn/ZnS magnetic QDs have been used to label and
visualise brain tissue without manipulating the blood–
brain-barrier. The ﬂuorescent visualisation of the whole rat
brain was achieved using a simple low power handheld UV
lamp [58].
Cell Tracking, Sorting and Bioseparation
The bioimaging techniques described above play an
important role in cytometry and cell tracking. In 1999,
Terstappen and co-workers [67] reported a new approach
Fig. 13 Cell type internalising
Cy5.5-CLIO as determined by
laser scanning confocal
microscopy. (a–e) Area from
tumour centre, original
magniﬁcation 2009.( a)
Distribution of Cy5.5-CLIO in
Cy5.5 channel; (b) GFP
channel; (c) anti-CD11b
staining for microglia and
macrophages in rhodamine
channel; (d) overlay of (a) and
(c); (e) overlay of (a) and (b).
Cy5.5-CLIO is internalised
predominantly by microglial
cells and inﬁltrating
macrophages. (f–h) Area from
tumour–brain interface, tumour
border in GFP channel; (g)
tumour border in rhodamine
channel (CD11b); (h) overlay of
(f) and (g). Cells positive for
CD11b extend slightly beyond
the border of GFP ﬂuorescence.
From [63]
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123for optical tracking and detection of immunomagnetically
selected and aligned cells. In this work, blood cells were
labelled with magnetic nanoparticles and ﬂuorescent
probes and aligned along ferromagnetic lines deposited by
lithographic techniques on an optically transparent surface
of a chamber under a magnetic ﬁeld (Fig. 14). An epiil-
lumination system, using a 635-nm laser diode, scanned the
lines and measured signals obtained from the aligned cells
giving the cell counts per unit of blood volume. This cell
analysis method was found to be signiﬁcantly less complex
and more sensitive than conventional cell analysis. In
addition, this method allows for repeated and varied anal-
yses to be carried out on the cells while they remain in a
natural environment (i.e. whole blood).
Development of two in one ﬂuorescent magnetic nano-
particles would be greatly beneﬁcial for further
development of this technique. In fact, dual ﬂuorescent
magnetic nanocomposites have demonstrated their great
potential for cytometry and cell sorting. A magneto/optical
annexin nanocomposite has recently been developed by
reacting an amino-CLIO magnetic nanoparticle with Cy5.5
and SPDP, to produce ﬂuorescent/magnetic, sulfhydryl
reactive nanohybrids. These nanocomposites demonstrate
good binding activity for apoptotic cells, while being
detectable by both ﬂuorescent and MRI modalities. These
multi-modal annexin composites can be used with
cell-based ﬂuorescence methods to select, separate and
apoptotic cells using an external magnetic ﬁeld [68]. It was
also reported that the detection of apoptotic cells can be
achieved by using lipid-based ﬂuorescent-magnetic nano-
composites covalently coupled to human recombinant
annexin A5 molecules. These composites consisted either
of iron oxide particles encapsulated within PEGylated
micelles or gadolinium chelate-based lipids trapped within
the lipid bilayer of PEGylated liposomes. The in vivo
detection and visualisation of apoptosis could enable early
detection of therapy efﬁciency and evaluation of disease
progression [45].
Visual sorting and manipulation of apoptotic cells using
ﬂuorescent-magnetic multi-functional nanospheres was
also reported by Pang and co-workers [69]. These ﬂuores-
cent-magnetic nanospheres were formed by co-embedding
QDs and magnetite nanoparticles into hydrazide-function-
alised copolymer nanospheres, which were then covalently
coupled on the surface with IgG, avidin and biotin to gen-
erate ﬂuorescent-magnetic bio-targeting trifunctional
nanospheres. These nano-bio-composites can selectively
link to apoptotic cells, allowing their visualisation and
isolation [69]. Similar types of ﬂuorescent-magnetic nano-
composites have also been used by the same group
to capture, visualise and magnetically separate various
speciﬁc cancer cells [70].
The functionalisation of nanocomposites, consisting of a
polymer-coated maghemite superparamagnetic core and a
CdSe/ZnS QD shell, with anticycline E antibodies, has
permitted the separation of MCF-7 breast cancer cells from
serum solutions. The surface immobilised anticycline E
antibodies bound speciﬁcally to cyclin, a protein which is
expressed on the surface of breast cancer cells. The sepa-
rated cells were monitored by ﬂuorescence imaging
microscopy, due to the strong luminescence of these
nanocomposite particles [36]. An interesting external
‘‘magnetic motor effect’’ on ﬂoating cells, treated with
ﬂuorescent-magnetic nanocomposites, has been reported
by Lee and co-workers [71]. They used rhodamine B
isothiocyanate-labelled cobalt ferrite–silica magnetic
nanoparticles, which have been modiﬁed with PEG groups
and administered these nanocomposites to a breast cancer
cell culture. It was found that these nanocomposites were
delivered to the cytoplasm of living cells, allowing both
ﬂuorescent and magnetic labelling of the cells. In addition,
it was demonstrated by microscopy that moving the posi-
tion of an applied external magnet results in a fast change
in the direction of the cells containing magnetic nanopar-
ticles (a so-called ‘‘magnetic motor effect’’). This research
shows the great potential for magnetic-ﬂuorescent nano-
composites as reagents for cell labelling, bioseparation and
related applications.
Fluorescent-magnetic nanocomposites can be used to
isolate not only cells but also various biomolecules and
Fig. 14 Leukocytes aligned between ferromagnetic lines. Whole
blood was incubated with CD45-labelled ferromagnetic nanoparticles
and acridine orange. From [67]
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123other biological entities, allowing simultaneous control
over the process using ﬂuorescent microscopy. This is a
major advantage over conventional magnetic separation
techniques. For example, the detection and extraction of
antibodies from aqueous solutions, using ﬂuorescent mag-
netoliposomes, has been reported by Rosenzweig and
co-workers [72]. The ﬂuorescent magnetoliposomes consist
of cobalt platinum alloy nanoparticles encapsulated in
liposomes, which have been labelled with BODIPY-
Fluorescein dye. The monitoring of the extraction by
measuring the ﬂuorescence intensity allows determination
of the maximum extraction time.
Bio- and Chemo-sensing
Magnetic/ﬂuorescent nanocomposites offer unique oppor-
tunities for bio- and chemo-sensing. The dual properties of
these composites allow not only a detection of certain
entities using both magnetic resonance and ﬂuorescence
techniques but also enable them to be utilised as a type of
magnetic tweezers for positioning and manipulation of the
sensor in three dimensions. This is particularly important
for chemical and biological sensing in cellular environ-
ments. The pH sensitivity of magnetic nanospheres based
on iron oxide nanoparticles encapsulated within hollow
organically modiﬁed silica particles nanospheres that have
been ﬁlled with a pH sensitive dye [(9-(diethylamino)-5-[(2
octyldecyl)imino]benzo[a]phenoxazine)] has been recently
reported [73]. Swarms of these nanocomposites were
magnetically guided through a pH gradient, while mea-
suring their ﬂuorescence spectral emission. The magnetic
tweezers allowed control over the size and position of the
swarm magnetically, without direct mechanical contact
(Fig. 15).
In addition, the tweezers can reversibly assemble the
particles within the swarm into chains and control the
orientations of these chains. These new materials demon-
strate a unique ability for chemical sensing, while
providing options to simultaneously modulate ﬂuorescence
intensity, produce singlet oxygen, apply mechanical forces
and even measure chemical and physical properties of
ﬂuids and surfaces. The use of functionalised magnetic
particles for selective binding to low-abundance target
analytes and pre-concentrating them, allowing for the
removal of the sample matrix prior to the detection step, is
quite a popular strategy for DNA or virus sensing [74–77].
The utilisation of magnetic nanoparticles for magnetically
conﬁning and concentrating target analytes in a micro-
scopic volume for in situ optical detection signiﬁcantly
improves the selectivity and sensitivity of DNA sensors.
Normally, this approaches involves a ‘‘capture and release’’
system, in which the target DNA is captured by function-
alised magnetic particles, separated from the sample matrix
and then released in a suitable aqueous medium prior to
detection with the polymer-probe duplex. Boudreau and
co-workers [78] have developed new modiﬁed method
which eliminates the release and labelling of the hybridised
target DNA, prior to optical detection, by using a ﬂuores-
cent polymeric hybridisation transducer supported on
magnetic beads. This approach allows for both the pre-
concentration and detection steps to occur simultaneously
on the same support, resulting in rapid, ultrasensitive and
Fig. 15 Magnetic tweezer manipulation of a swarm of magnetised
ﬂuorescent-magnetic microspheres in a droplet. The 250 lm iron wire
magnetic tweezers were placed above the droplet to aggregate the
magnetic microspheres into a swarm. The iron wire was then abruptly
moved above the swarm to observe the velocity proﬁle of the swarm.
(a) Simultaneous bright ﬁeld and ﬂuorescence image of swarm and
iron wire above. (b) Fluorescence image of swarm before moving the
wire. (c) Moving the swarm left. (d) Moving the swarm right. (e)
Holding wire still. (f) Moving the wire and swarm down. From [73]
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123sequence-speciﬁc detection of DNA. The combination of
the ﬂuorescent polymer biosensor with the magnetic par-
ticle-assisted DNA pre-concentration could enable the
application of this sensoring technique to biological sam-
ples with complex matrixes and to integrated lab-on-a-chip
platforms for fast multi-target DNA detection.
Nanomedicine Applications
The term ‘‘nanoclinics’’ was initially introduced by Prasad
and co-workers [23], when their report on hierarchically
built nanoparticles for targeted diagnostics and therapy
appeared in 2002. These nanocomposites consist of a thin
functionalised silica shell encapsulating magnetic (Fe2O3)
nanoparticles and two-photon ﬂuorescent dyes. The silica
surface of these core-shell structures was functionalised
with aluteinising hormone-releasing hormone for speciﬁc
targeting of cancer cells. These nanocomposites have
potential applications as MRI contrast agents, optical
imaging diagnostic tools and as magnetic-induced cancer
therapy devices.
Xu et al. [53] have reported porphyrin—iron oxide
nanoparticles conjugates, which can be utilised as bimodal
anticancer agents for combined PDT and hyperthermia
therapy. These conjugates can be effectively taken up by
cancer HeLa cancer cells. The exposure of the cells con-
taining the nanocomposites to yellow light resulted in a
signiﬁcant change of their morphology due to the cell
apoptosis. These results demonstrate a potential of these
nanoparticles for cancer therapy.
An interesting experiment was performed using
magnetic-ﬂuorescent polymer capsules, which were
simultaneously functionalised with magnetic nanoparticles
and ﬂuorescent CdTe nanocrystals. These nanocomposites
have been used for modelling the bloodstream in a ﬂow
channel system under a magnetic ﬁeld gradient, which
allowed for the speciﬁc trapping of polymer capsules. In
the regions where the capsules were trapped by the mag-
netic ﬁeld, an increased uptake of the capsules by breast
cancer cells was observed due to the high local concen-
tration of the composites. The process was monitored by
ﬂuorescence microscopy. These results demonstrate the
potential use the multi-modal ﬂuorescent-magnetic poly-
mer capsules loaded with pharmaceutical agents for
targeted drug delivery and cancer therapy [79].
Veiseh et al. [80] have prepared magnetite nanoparticles
with a polyethylene glycol coating and have subsequently
functionalised these with chlorotoxin (Cltx), a glioma
tumour-targeting molecule and the ﬂuorescent molecule
Cy5.5. They have shown that the nanoparticle-Cltx
conjugates target glioma tumour cells and that this inter-
nalisation into the cells can be visualised by confocal
imaging. The reported T2 relaxation times (5 ms for the
Cltx coated particles, 95 ms without) are promising for
glioma detection. They have also demonstrated an afﬁnity
of these nanocomposites for glioma cells over healthy tis-
sues. Targeted cancer imaging has been investigated by
Choi et al. [81] using folate-treated magnetic nanoparti-
cles. The folate receptor is a protein which is over-
expressed in various types of human tumours, where it acts
to capture folate to feed rapidly dividing tumour cells. The
idea here was to use dextran-coated magnetic nanoparticles
which were tethered to folic acid and a ﬂuorescent imaging
agent (ﬂuorescein thioisocyanate). In this way, once the
particles were internalised into the cancer cells, it was
possible to obtain and analyse a tumour image in vivo. The
resulting T2-weighted MR images reveal a 38% decrease in
the intensity of the tumour tissue owing to the presence of
the folate-coated nanoparticles (Fig. 16a, b). Internalisation
was also conﬁrmed using confocal imaging of human
carcinoma cells which express the surface receptors for
folic acid (Fig. 16c).
Conclusions and Future Outlook
In this review, we have shown that many ﬂuorescent-
magnetic nanocomposites of different varieties have been
developed over recent years. There is a great need and
demand for these materials. From above discussion, it is
clear that magnetic-ﬂuorescent nanocomposites offer new
approaches and opportunities in chemistry, biology and
medicine. However, despite of all recent progress made,
the ﬂuorescent-magnetic nanocomposite area is still in its
infant stage and signiﬁcant efforts are needed for further
development of these materials and their utilisation. We
believe that in the long-term new ﬂuorescent-magnetic
nanomaterials could serve as all in one diagnostic, surgery
and nano-sized drug delivery tools, which could help in the
diagnosis and treatment of cancer, HIV and many other
Fig. 16 (a, b)T 2-weighted MR
images of tumour cells before
and after magnetic ﬂuid
administration and (c) confocal
imaging of cells with
internalised magnetic ﬂuid.
From [81]
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123diseases. Because of their small size and combination of
magnetic and ﬂuorescent properties, these nanocomposites
open up the unique possibility of controlled target-directed
applications. This is of particularly great importance in
medicine, as one major disadvantage of any nanoparticle
therapy is the problem of getting the particle to the site of
interest. An external magnetic ﬁeld could be used to attract
the multi-modal ﬂuorescent-magnetic nanocomposites to
the desired area, to hold them there until the diagnostic or
treatment is complete and ﬁnally to remove them. All steps
can be monitored by MRI and ﬂorescence microscopy
allowing the full control over the processes. Thus, further
development and utilisation of magnetic-ﬂuorescent
nanoprobes could revolutionise many aspects of modern
medicine. However, toxicity is of major concern when
advocating nanoparticles for any biomedical use. Unfor-
tunately toxicity of nanomaterials is still very poorly
studied and understood. There is a recent report on the
reduced toxicity for the gelatine-coated CdTe QD nano-
composites and their potential as bioimaging agents [82].
We believe similar approaches can be used for the devel-
opment of certain ﬂuorescent-magnetic nanocomposites
with low toxicity. A signiﬁcant part of the future work in
this area must be focused on the investigation of the tox-
icity and improvement of biocompatibility of multi-modal
nanocomposites. This will be crucial for further develop-
ment of this very important ﬁeld of nano-biotechnology.
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